Filters
Other countries
Results: 1 to 12 of 12
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Frontotemporal Dementia with C9orf72 Panel Invitae United States | 30 | 14 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
TBK1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae United States | 72 | 33 |
|
Invitae Frontotemporal Dementia Panel Invitae United States | 29 | 13 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Encephalopathy, acute, infection-induced: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 8 | 8 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.